Annie Thériault, Managing Partner at CBIV, has been immersed in impact investing, venture capital, royalty financing, and capital markets throughout her career. As a venture capital investor and venture advisor, she worked with high impact companies to mobilize more than $100 million in non-dilutive capital. Annie was previously a director on the boards of several North American venture-backed companies, is an advisor to crowdfunding fintech company FrontFundr, and, prior to the launch of CBIV, was Chief Investment Officer at Grand Challenges Canada. Annie obtained her PhD in Management from the Rotman School of Management at the University of Toronto, is a CFA Charterholder, and holds the ICD.D designation. She also has a master’s degree in Business Economics from Wilfrid Laurier University and a Bachelor of Science with First Class Honours in Chemistry from Mount Allison University.

Donna Parr, Managing Partner at CBIV, has more than 30 years of experience managing venture capital, growth equity, and private debt investment portfolios of up to $1 billion. She has managed two biotech related funds (GrowthWorks Canadian Fund and Canadian Medical Discoveries Fund) and has held roles at several notable pension funds and firms, including OMERS, CPP, and TD Capital. She is currently on the boards of Constellation Software and Topicus.com. Donna holds a master’s degree in International Relations from the University of Toronto and earned her MBA from Schulich School of Business. She holds the ICD.D designation.

Cyriac Alappat, Principal at CBIV, brings to the team expertise in global health, international partnership networks, early-stage growth and financing as well as organizational behavior. Cyriac was part of the founding team of CBIV. Prior to the launch of the firm, he was an investment manager for the Every Woman Every Child Innovation Marketplace at Grand Challenges Canada, a highly successful platform that supported the fundraising efforts of a portfolio of over 40 early-stage high impact health companies based in North America, Africa and India towards mobilizing $46M in equity and non-dilutive financing. Cyriac often brings the view of the founder to the table, having joined Grand Challenges Canada, after a number of years operating a FinTech company he co-founded to accelerate the angel investment process and scaling in the MENA region. Cyriac started his career at an executive recruiting firm after obtaining his Chartered Accountant (CPA, CA) designation as part of the audit practice of E&Y. Cyriac earned a Bachelor’s Degree in Business Administration from Wilfrid Laurier University.

Megan Dover, Principal at CBIV, has more than 14 years of experience in impact investing, venture advisory, M&A, business strategy, Financial Planning & Analysis and angel investing. Megan was part of the founding team of CBIV. Prior to the launch of the firm, she was an investment manager for the Every Woman Every Child Innovation Marketplace at Grand Challenges Canada, a highly successful platform that supported the fundraising efforts of a portfolio of over 40 early-stage high impact health companies based in North America, Africa and India towards mobilizing $46M in equity and non-dilutive financing. Megan brought expertise in a number of areas to the role, having previously held roles in finance and strategy for a public resource company, worked in management consulting for a global consulting firm, been part of an R&D team for a biotech startup and as an advisor and angel investor at the Creative Destruction Lab (CDL). Megan obtained her MBA from the Rotman School of Management at the University of Toronto, receiving a Dean’s list ranking. She also earned her Engineering degree with Honours from Queen’s University, specializing in Biomedical Research within Chemical Engineering.

Dr. Jenkins serves as the Dean of UofSC School of Medicine Greenville and as Chief Academic Officer for Prisma Health-Upstate. In 2015, Dr. Jenkins was invited to join the U.S. Food and Drug Administration’s Office of Women’s Health (FDA OWH). Within this role, Dr. Jenkins led, and disseminated research, education and health policy initiatives across the agency, and other federal and academic environments. Her past academic appointments include tenured Professor of Medicine, Associate Dean for Women in Medicine and Science, Founding Executive Director and Chief Scientific Officer for the Laura W. Bush Institute for Women’s Health, and held the J. Avery Rush Endowed Chair for Excellence in Women’s Health Research. Dr. Jenkins also served as Director of the Johns Hopkins Master in Education for Health Professions graduate student research program. In addition to her academic accomplishments, Dr. Jenkins continues to practice as a dedicated clinician providing personalized care to thousands of men and women throughout her medical career.

Dr. McGregor is a women’s health pioneer who has survaced the importance of of sex and gender differences in the delivery of healthcare to the US national stage. She holds the position of Associate Dean of Clinical Faculty Affairs and Development and Professor, Department of Emergency Medicine at University of South Carolina School of Medicine, Greenville. Dr. McGregor is also a Co-Founder of the National Organization Sex and Gender Women’s Health Collaborative. Dr. McGregor’s research focuses on how sex and gender matter when studying, diagnosing a treating patients with medical conditions. She is a leader in this topic , speaking widely to both medical professionals and laypeople throughout north america. Her TEDx talk, “Why Medicine Often Has Dangerous Side Effects for Women,” currently has over 1.5 million views, and has sparked a national conversation around the work on how sex and gender influence medical treatment and outcomes. She has authored over sixty peer-reviewed publications in scientific journals on the topic of sex and gender. She is also the lead editor for the medical textbook, Sex and Gender in Acute Care Medicine (Cambridge University Press, 2016).

Dr. Zulfiqar A. Bhutta is the Robert Harding Inaugural Chair in Global Child Health at the Hospital for Sick Children, Toronto and co-Director of the SickKids Centre for Global Child Health. He is also the Founding Director of the Center of Excellence in Women and Child Health at the Aga Khan University,. Furthermore, Dr. Bhutta holds adjunct professorships at several leading universities globally, including the Schools of Public Health at Johns Hopkins (Baltimore), Tufts University (Boston), University of Alberta, as well as the London School of Hygiene & Tropical Medicine. He is a designated Distinguished National Professor of the Government of Pakistan and was the Founding Chair of the National Research Ethics Committee of the Government of Pakistan from 2003 to 2014. Dr. Bhutta is part of the seven-member Independent Expert Review Group (iERG) appointed by the UN Secretary General for monitoring global progress in maternal and child health Millennium Development Goals (MDGs). He represents the global academic and research organizations on the GAVI Alliance Board, and is the co-Chair of the Maternal and Child Health oversight committee of the World Health Organization’s Eastern Mediterranean Regional Office as well as the Global Countdown for 2015 Steering Group.

Dr. Merialdi is the Senior Director at Becton Dickinson (BD) Global Health. In this role, he is tasked leads the maternal and newborn health strategy and works to strengthen BD’s technologies and brand within this underserved market . For example, he is currently working together with the BD’s Medical Affairs team , BD’s geographic departments and with the Greater Asia R&D teams to advance plans for clinical trials and development of the BD Odon Device. Prior to joining BD, Dr. Merialdi served as the coordinator of Human Reproduction and as a Medical Officer in the Maternal and Perinatal Health Research Unit at the World Health Organization in Geneva, Switzerland. He worked in the design, implementation and coordination of large multinational epidemiological studies involving research institutions in developed and developing countries. Dr. Merialdi obtained a degree in Medicine at the University of Parma in 1991 and completed the residency in Obstetrics and Gynecology at the same University in 1995. From 1995 to 2001, he attended the Bloomberg School of Public Health in Baltimore, USA, where he obtained a Masters of Public Health in 1996 and a PhD in 2001. As a part of his PhD program he was in Peru from 1998 to 2001 to run a study of prenatal zinc supplementation and fetal growth and neurobehavioral development.